Literature DB >> 17349971

Small GTPase Rho signaling is involved in beta1 integrin-mediated up-regulation of intercellular adhesion molecule 1 and receptor activator of nuclear factor kappaB ligand on osteoblasts and osteoclast maturation.

Fumihiko Hirai1, Shingo Nakayamada, Yosuke Okada, Kazuyoshi Saito, Hitoshi Kurose, Akira Mogami, Yoshiya Tanaka.   

Abstract

We assessed the characteristics of human osteoblasts, focusing on small GTPase Rho signaling. Beta1 Integrin were highly expressed on osteoblasts. Engagement of beta1 integrins by type I collagen augmented expression of intercellular adhesion molecule 1 (ICAM-1) and receptor activator of nuclear factor kappaB ligand (RANKL) on osteoblasts. Rho was activated by beta1 stimulation in osteoblasts. Beta1 Integrin-induced up-regulation of ICAM-1 and RANKL was inhibited by transfection with adenoviruses encoding C3 transferase or pretreated with Y-27632, specific Rho and Rho-kinase inhibitors. Engagement of beta1 integrin on osteoblasts induced formation of tartrate-resistant acid phosphatase (TRAP)-positive multinuclear cells (MNC) in a coculture system of osteoblasts and peripheral monocytes, but this action was completely abrogated by transfection of C3 transferase. Our results indicate the direct involvement of Rho-mediated signaling in beta1 integrin-induced up-regulation of ICAM-1 and RANKL and RANKL-dependent osteoclast maturation. Thus, Rho-mediated signaling in osteoblasts seems to introduce major biases to bone resorption.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17349971     DOI: 10.1016/j.bbrc.2007.02.121

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  HIV-1 Tat triggers nuclear localization of ZO-1 via Rho signaling and cAMP response element-binding protein activation.

Authors:  Yu Zhong; Bei Zhang; Sung Yong Eum; Michal Toborek
Journal:  J Neurosci       Date:  2012-01-04       Impact factor: 6.167

2.  Alpha1beta1 integrin and interleukin-7 receptor up-regulate the expression of RANKL in human T cells and enhance their osteoclastogenic function.

Authors:  Steve Gendron; Marc Boisvert; Nizar Chetoui; Fawzi Aoudjit
Journal:  Immunology       Date:  2008-05-13       Impact factor: 7.397

3.  Collagen inhibitory peptide R1R2 mediates vascular remodeling by decreasing inflammation and smooth muscle cell activation.

Authors:  Ting-Hein Lee; Jane Sottile; Hou-Yu Chiang
Journal:  PLoS One       Date:  2015-02-12       Impact factor: 3.240

4.  SLPI is a critical mediator that controls PTH-induced bone formation.

Authors:  Akito Morimoto; Junichi Kikuta; Keizo Nishikawa; Takao Sudo; Maki Uenaka; Masayuki Furuya; Tetsuo Hasegawa; Kunihiko Hashimoto; Hiroyuki Tsukazaki; Shigeto Seno; Akira Nakamura; Daisuke Okuzaki; Fuminori Sugihara; Akinori Ninomiya; Takeshi Yoshimura; Ryoko Takao-Kawabata; Hideo Matsuda; Masaru Ishii
Journal:  Nat Commun       Date:  2021-04-09       Impact factor: 14.919

5.  Stimulation of osteoclast formation by RANKL requires interferon regulatory factor-4 and is inhibited by simvastatin in a mouse model of bone loss.

Authors:  Yoshiki Nakashima; Tatsuji Haneji
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

6.  Molecular association of CD98, CD29, and CD147 critically mediates monocytic U937 cell adhesion.

Authors:  Mi-Yeon Kim; Jae Youl Cho
Journal:  Korean J Physiol Pharmacol       Date:  2016-08-26       Impact factor: 2.016

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.